+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Treatment of progressive supranuclear palsy and corticobasal degeneration



Treatment of progressive supranuclear palsy and corticobasal degeneration



Movement Disorders 20(Suppl. 12): S83



Success in treating patients with progressive supranuclear palsy and corticobasal degeneration remains exceedingly low. This finding probably relates to the widespread distribution of the pathological changes that account for the varied and complex spectrum of clinical manifestations. Dopaminergic drugs are regularly used for the parkinsonian features; however, these rarely result in more than modest benefit, and when better or sustained responses are obtained, as sometimes occurs in progressive supranuclear palsy, the clinical features are atypical and diagnosis is often delayed or not made in life. A variety of other treatments have been used in both disorders, sometimes directed at other specific features such as dystonia or myoclonus, and these treatments will be reviewed. Greater success in treating these disorders will require advances in our understanding of their cause(s) or the pathogenetic mechanisms underlying the neurodegenerative processes. The similarities in the molecular pathology of these four-repeat tauopathies suggests that important advances in the management of one will have a definite impact on the treatment of the other.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 050845627

Download citation: RISBibTeXText

PMID: 16092096

DOI: 10.1002/mds.20545


Related references

Corticobasal degeneration: widespread argentophilic threads and glia in addition to neurofibrillary tangles. Similarities of cytoskeletal abnormalities in corticobasal degeneration and progressive supranuclear palsy. Journal of the Neurological Sciences 138(1-2): 66-77, 1996

Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options. Current Treatment Options in Neurology 18(9): 42, 2016

Progressive supranuclear palsy and corticobasal degeneration. Bailliere's Clinical Neurology 6(1): 167-185, 1997

Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration. Journal of Neuropathology and Experimental Neurology 60(6): 647-657, 2001

Similarities and differences among progressive among progressive supranuclear palsy, corticobasal degeneration and Pick's disease. Neuropathology 16(4): 262-268, 1996

Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: Tau pathologies with exclusively exon 10 isoforms. Journal of Neurochemistry 72(3): 1243-1249, 1999

Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy. International Review of Psychiatry 25(2): 197-209, 2013

Links between frontotemporal lobar degeneration, corticobasal degeneration, progressive supranuclear palsy, and amyotrophic lateral sclerosis. Alzheimer Disease and Associated Disorders 21(4): S31, 2007

Visual event-related potentials in progressive supranuclear palsy, corticobasal degeneration, striatonigral degeneration, and Parkinson's disease. Journal of Neurology 247(5): 356-363, 2000

Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy. Journal of the Neurological Sciences 289(1-2): 138-143, 2010

Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration. Neuropathology 24(1): 79-86, 2004

Progressive supranuclear palsy and corticobasal degeneration: similarities and differences. Future Neurology 3(3): 299-307, 2008

Glial abnormalities in progressive supranuclear palsy and corticobasal degeneration. Zhonghua Bing Li Xue Za Zhi 33(2): 125-129, 2004

Neuropsychological comparison between corticobasal degeneration and progressive supranuclear palsy. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 37(7): 541-547, 2000

Procerus sign in progressive supranuclear palsy and corticobasal degeneration. Internal Medicine 41(12): 1101-1102, 2002